|
Web Counter: 29103 visitors
|
00 days left
to the Congress
|
|
Scientific Programme at the Glance can be downloaded here.
Please see also Detailed Scientific Programme bellow.
Detailed Scientific Programme
Thursday, May 1, 2008
| 09:00 – 15:30 |
|
Colposcopy Course |
| |
|
Lukáš Rob, Charles W. E. Redman, Carl Chow, Joseph Jordan, Marek Pluta |
| |
|
|
| |
|
Chair: Vladimír Vonka |
| |
|
|
| 16:00 – 17:00 |
|
Neoplastic Diseases Caused by Viruses |
| |
|
Ivan Hirsch |
| |
|
|
| 17:00 – 18:00 |
|
The History of Papillomavirus Research |
| |
|
Stina Syrjanen |
| |
|
|
| 18:00 – 20:00 |
|
WELCOME COCKTAIL |
Friday, May 2, 2008
| |
|
Chair: Marek Pluta |
| |
|
|
| 07:30 – 8:45 |
|
Each presentation is scheduled for 7 minutes |
| |
|
|
| |
OP–01 |
HPV and Bladder Cancer: A New Challenge for the Urological Research |
| |
|
Sandra Mazzoli |
| |
|
|
| |
OP-03 |
Prognostics Relevance of the Detection of HPV High Risk DNA Types 16, 16 & 45 Using the QIAGEN HPV 16/18/45 Probe Set in HPV High Risk Positive Specimens: First Result |
| |
|
Sven Tiews |
| |
|
|
| |
OP-04 |
New High-throughput Method for Oncogenic Human Papillomaviruses genotyping by multiplex Fluorescent PCR (f-HVP typing) in 4051 cervical samples |
| |
|
Paz Cañadas |
| |
|
|
| |
OP-05 |
HPV Infections among Adolescent Population and High School Rock Concerts for Education of Humanpapillomaviruses |
| |
|
Dubravko Lepusic |
| |
|
|
| |
OP-06 |
Combined HPV Genotyping and Cell-Based E6, E7 mRNA (HPV OncoTect) Detection in Cervical Cytology Specimens Performed on a Molecular Hybrid Platform (MoHP) Maximizes Sensitivity and Positive Predictive |
| |
|
Bruce Patterson |
| |
|
|
| |
OP-07 |
Evaluation of 16,18,45 HPV DNA Probe – Comparation with Cervical Cytology and Follow Up |
| |
|
Danijela Vrdoljak-Mozetič |
| |
|
|
| |
OP-08 |
Conjunctive Use of the Cervatec p16 ELISA Significantly Increases the Sensitivity for Detection of CIN2+ Over Conventional Pap Cytology Alone - Results from a Prospective Screening Trial |
| |
|
Petra Klement |
| |
|
|
| |
OP-09 |
HPV E6, E7 mRNA Expression in Ectocervical Cells (HPV OncoTect) Predicts Disease Progression in Women with Low Grade Intraepithelial Neoplasia (LSIL) |
| |
|
Francisco Alameda |
| |
|
|
| 08:45 – 09:00 |
|
MORNING COFFEE |
| |
|
|
| 09:00 – 09:15 |
|
HPV in Cervical Cancer Research Grant |
| |
|
Chris Meijer, Joakim Dillner |
| |
|
|
| |
|
Chair: Ethel-Michele de Villiers |
| |
|
|
| 09:15 - 09:45 |
|
Epidemiology of HPV infection |
| |
|
Gary Clifford |
| |
|
|
| 09:45 – 10:15 |
|
Immunology of HPV |
| |
|
Sjoerd van der Burg |
| |
|
|
| 10:15 – 10:45 |
|
HPV Infection in Women |
| |
|
Lukáš Rob |
|
|
|
| 10:45 – 11:05 |
|
COFFEE BREAK |
| |
|
|
| |
|
Chair: Šárka Němečková |
| |
|
|
| 11:05 – 11:35 |
|
HPV Prevalance and Type Distribution in Ano-genital Cancers other than Cervical Cancer |
| |
|
Silvia Franceschi |
| |
|
|
| 11:35 – 11:55 |
|
HPV Infection and Head and Neck Diseases |
| |
|
Ruth Tachezy, Jan Klozar |
| |
|
|
| 11:55 – 12:15 |
|
Development of Clinically Effective Therapeutic HPV Vaccines |
| |
|
Sjoerd van der Burg |
| |
|
|
| 12:15 – 12:30 |
|
LUNCH BREAK |
| |
|
|
| 12:30 – 14:00 |
|
MSD Satellite Symposium in "HPV in Human Pathology Congress" |
| |
|
Primary Cervical Cancer Prevention and Beyond |
| |
|
|
| |
|
Chairman: Prof. MUDr. Roman Prymula, CSc., Ph.D. |
| |
|
|
| |
|
Need for collaborative effort |
| |
|
Prof. MUDr. Roman Prymula, CSc., Ph.D. |
| |
|
|
| |
|
Underlining the clinical efficacy - Sustained protection by a Quadrivalent HPV vaccine |
| |
|
Prof. Ole-Erik Iversen, MD, Phd |
| |
|
|
| |
|
Global approach: recommendations & guidelines |
| |
|
Prof. MUDr. Roman Prymula, CSc., Ph.D. |
| |
|
|
| |
|
|
| |
|
Chair: Marc Van Ranst |
| |
|
|
| 14:00 – 14:30 |
|
HPV DNA Detection |
| |
|
Peter J. F. Snijders |
| |
|
|
| 14:30 – 15:00 |
|
Detection of HPV Specific Antibodies |
| |
|
Michael Pawlita |
| |
|
|
| 15:00 – 15:30 |
|
Standards, Quality Assurance |
| |
|
Lena Dillner |
| |
|
|
| 15:30 – 15:50 |
|
COFFEE BREAK |
| |
|
|
| |
|
Chair: Jaroslava Dušková |
| |
|
|
| 15:50 – 16:20 |
|
Liquid compared with Conventional Cervical Cytology |
| |
|
Christine Bergeron |
| |
|
|
| 16:20 – 16:50 |
|
LBC in UK Screening |
| |
|
Amanda Herbert |
| |
|
|
| 16:50 – 17:20 |
|
Cyto and HPV in Finland |
| |
|
Ahti Anttila |
| |
|
|
| 17:20 – 17:40 |
|
COFFEE BREAK |
| |
|
|
| 17:40 – 18:25 |
|
Pro X Con, Cyto, HPV, Both |
| |
|
Christine Bergeron, Chris Meijer, Joakim Dillner |
| |
|
Each presentation - 15 minutes, discussion |
Saturday, May 3, 2008
| |
|
Chair: Jan Klozar |
| |
|
|
| 07:30 – 8:45 |
|
Each presentation is scheduled for 7 minutes |
| |
|
|
| |
OP-10 |
HPV Infection in Mothers of Children with Recurrent Respiratory Papillomatosis |
| |
|
Nathalia Babkina |
| |
|
|
| |
OP-11 |
Comparison of Clinical Potential of Vaccine-related Types (16-18) and Other HR-HPV Types in Follow-Up of Women with Squamous Intraepithelial Lesions of the Uterine Cervix |
| |
|
Carmine Carriero |
| |
|
|
| |
OP-12 |
Exposure of HPV31b Infected Keratinocytes to Cigarette Smoke Carcinogen Benzo[a]pyrene Results in Alteration of Host Cell Cycle Profile and Viral Life Cycle |
| |
|
Craig Meyers |
| |
|
|
| |
OP-13 |
Does the Easy-to-make Penile Lesions Detection Test Help Us in Routine Diagnosis of High-Risk Human Papillomavirus Types (hrHPV)in Men? |
| |
|
Vitaly Smelov |
| |
|
|
| |
OP-14 |
Effect of HPV on Treatment Outcome and Survival in Oropharyngeal Carcinoma - a Subgroup Analysis of the Randomized DAHANCA 5&7 Trials |
| |
|
Pernille Lassen |
| |
|
|
| |
OP-15 |
Is HPV Vaccination Cost-Effective in the Dutch Situation? |
| |
|
Inge de Kok |
| |
|
|
| |
OP-16 |
Native Versus Synthetic Papillomavirus Particles |
| |
|
Craig Meyers |
| |
|
|
| |
OP-17 |
High-Risk Human Papillomavirus Screened on 1,686 Italian Patients: Epidemiological, Clinical and Vaccinal Implications |
| |
|
Sandra Mazzoli |
| |
|
|
| |
OP-18 |
A Comparison of Performance Parameters for Cervical Cancer Screening in European Countries |
| |
|
Guglielmo Ronco |
| |
|
|
| 08:45 – 09:00 |
|
MORNING COFFEE |
| |
|
|
| |
|
Chair: Marc Arbyn |
| |
|
|
| 09:00 – 09:15 |
|
Screening - Introduction |
| |
|
Marc Arbyn |
| |
|
|
| 09:15 – 10:15 |
|
The EU 15 |
| |
|
Finland, France, Sweden, Holland, UK (5x10 min) |
| |
|
Ahti Anttila, Christine Bergeron, Joakim Dillner, Chris Meijer, Amanda Herbert |
| |
|
Discussion |
| |
|
|
| 10:15 – 10:45 |
|
COFFEE BREAK |
| |
|
|
| 10:45 – 11:45 |
|
The New EU & Candidate Countries |
| |
|
Poland, Czech Republic, Croatia, Slovakia, Slovenia (5x10 min) |
| |
|
Marek Spaczynski, Ruth Tachezy, Magdalena Grce, Helena Hupková, Maja Zakelj |
| |
|
Discussion |
| |
|
|
| 11:45 – 12:00 |
|
Screening - Conclusions |
| |
|
Marc Arbyn |
| |
|
|
| 12:00 – 13:00 |
|
LUNCH BREAK |
| |
|
|
| |
|
Chair: Philips Davies |
| |
|
|
| 13:00 – 13:30 |
|
HPV Awareness and Education |
| |
|
|
| 13:00 – 13:10 |
|
Awareness of HPV and Cervical Cancer in Europe |
| |
|
Philip Davies |
| |
|
|
| 13:10 – 13:20 |
|
WHO Europe – Programmes to Raise Awareness of Cervical Cancer Prevention |
| |
|
Gunta Lazdane |
| |
|
|
| 13:20 – 13:30 |
|
Awareness and Education in the Czech Republic |
| |
|
Jana Petrenko |
| |
|
|
| 13:30 – 14:30 |
|
Vaccines – Controversaries |
| |
|
|
| 13:30 – 13:45 |
|
Vaccination of Infected Women and HPV Typing before Vaccination |
| |
|
Ole-Erik Iversen |
| |
|
|
| 13:45 – 14:00 |
|
Vaccination of Men |
| |
|
Joakim Dillner |
| |
|
|
| 14:00 – 14:15 |
|
Benefit of vaccination for other HPV related diseasses |
| |
|
Gary Clifford |
| |
|
|
| 14:15 – 14:30 |
|
Discussion |
| |
|
|
| 14:30 – 16:00 |
|
SESSION I. |
| |
|
Gynecology Clinic |
| |
|
Lukáš Rob, Charles W.E. Redman, Joseph Jordan |
| |
|
|
| 14:30 – 14:50 |
|
European Guidelines – Management of Abnormal Cytology |
| |
|
Joseph Jordan |
| |
|
|
| 14:50 – 15:10 |
|
Guidelines for the Management of the Precancerous Lesions |
| |
|
Charles Redman |
| |
|
|
| 15:10 – 15:30 |
|
Less Radical Fertility Sparing Surgery than Radical Trachelectomy in Early Cervical Cancer |
| |
|
Marek Pluta |
| |
|
|
| 15:30 – 15:40 |
OP-19 |
DNA HR HPV in Cervical Cancer Tissue, in Sentinel and Other Pelvic Lymph Nodes - a Correlation with Histopathological and Imunohistochemical Results |
| |
|
Jiří Sláma |
| |
|
|
| 15:40 – 15:50 |
|
HPV Profile for Vulvar Leasions |
| |
|
Petr Škapa |
| |
|
|
| 15:50 – 16:00 |
|
Discussion |
| |
|
|
| 14.30 – 16.00 |
|
SESSION II. |
| |
|
Head and Neck |
| |
|
Jan Klozar, Stina Syrjanen, Lalle Hammarstedt, Kateřina Lehovcová, Ruth Tachezy |
| |
|
|
| 14.30 – 14.50 |
|
Natural history of oral HPV infection-what do we know |
| |
|
Stina Syrjanen |
| |
|
|
| 14.50 – 15.05 |
|
Recurrent respiratory papillomatosis in children age |
| |
|
Kateřina Lehovcová |
| |
|
|
| 15.05 – 15.20 |
|
Tonsillar cancer: incidence, prevalence of HPV and survival |
| |
|
Lalle Hammarstedt |
| |
|
|
| 15.20 – 15.30 |
|
The role of HPV as risk and prognostic factor in HNSCC |
| |
|
Jan Klozar |
| |
|
|
| 15.30 – 15.40 |
|
The methods of selection of patients at risk of HPV associated head and neck tumors |
| |
|
Ruth Tachezy |
| |
|
|
| 15.40 – 16.00 |
|
Discussion |
| |
|
|
| |
|
|
-
|
|
